Cordillera, Caeli Nova’s patented technology to improve passenger oxygenation in the event of an emergency decompression on aircrafts, is being co-developed with Airbus. The proceeds from its series A round led by Ornament will enable the startup to enhance the technology and accelerate market entry.
Caeli Nova’s journey began after one of the founders learned about the limitations of existing aircraft oxygen systems – they required pilots to follow a route that allowed for rapid descent to a mandated safe altitude in the rare event of an emergency decompression. As a result, pilots avoided high terrain routes, even if they were more direct.
Its flagship product, Cordillera, is an advanced cabin emergency oxygen system for commercial and military passenger aircraft. Featuring the company’s patented technology, it will help overcome limitations associated with the existing technology while significantly reducing costs and carbon emissions for airlines by enabling aircraft to fly the most direct routes. In addition, Cordillera will deliver optimised payload planning, especially for twin-engine aircraft and weight savings compared to existing legacy systems.
In September 2021, the company signed a co-development partnership agreement with Airbus to enhance technical collaboration on Cordillera for use onboard Airbus aircraft. The company is aiming to install Cordillera onto the first aircraft in 2022.
A new investment round led by Ornament Health, a Swiss digital health company, will enable Caeli Nova to accelerate development as it heads towards market launch. LG Capital, a Switzerland-based venture builder and co-founder of Caeli Nova, spearheaded the company’s CHF 8m series A financing round, which has drawn investments from both the healthcare and the aviation sectors. Other primary financing partners participating in this round included Latécoère, a leading stock market listed Tier 1 aerospace manufacturer.
Initial funding in Caeli Nova has also included a Seed financing round and grant support from the UK government via the Innovate UK programme. The company employs 40 specialists from across the medical and aerospace sectors in the UK and Switzerland.
(Press release/RAN)
Please login or sign up to comment.
Commenting guidelines